Search by Drug Name or NDC
NDC 71610-0182-60 Magnesium Oxide 400 mg/1 Details
Magnesium Oxide 400 mg/1
Magnesium Oxide is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is MAGNESIUM OXIDE.
MedlinePlus Drug Summary
Magnesium is an element your body needs to function normally. Magnesium oxide may be used for different reasons. Some people use it as an antacid to relieve heartburn, sour stomach, or acid indigestion. Magnesium oxide also may be used as a laxative for short-term, rapid emptying of the bowel (before surgery, for example). It should not be used repeatedly. Magnesium oxide also is used as a dietary supplement when the amount of magnesium in the diet is not enough. Magnesium oxide is available without a prescription.
Related Packages: 71610-0182-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Magnesium Oxide
Product Information
NDC | 71610-0182 |
---|---|
Product ID | 71610-182_1c7508c2-75cf-41b4-9172-89f4e7054368 |
Associated GPIs | 48400020000310 |
GCN Sequence Number | 078687 |
GCN Sequence Number Description | magnesium oxide TABLET 400 MG ORAL |
HIC3 | D4B |
HIC3 Description | ANTACIDS |
GCN | 45064 |
HICL Sequence Number | 000609 |
HICL Sequence Number Description | MAGNESIUM OXIDE |
Brand/Generic | Generic |
Proprietary Name | Magnesium Oxide |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Magnesium Oxide |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 400 |
Active Ingredient Units | mg/1 |
Substance Name | MAGNESIUM OXIDE |
Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part331 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 71610-0182-60 (71610018260)
NDC Package Code | 71610-182-60 |
---|---|
Billing NDC | 71610018260 |
Package | 90 TABLET in 1 BOTTLE (71610-182-60) |
Marketing Start Date | 2018-10-28 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 11b2ce71-61fd-4e75-a859-a260b1dda080 Details
ACTIVE INGREDIENT (In each tablet)
WARNINGS
Ask a doctor or pharmacist before use if you are:
taking a prescription drug. Antacids may interact with certain prescription drugs.
DIRECTIONS
OTHER INFORMATION
INACTIVE INGREDIENTS
Repackaging Information
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma - TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
Count | 400 mg |
90 | 71610-182-60 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20181107JH
INGREDIENTS AND APPEARANCE
MAGNESIUM OXIDE
magnesium oxide tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Aphena Pharma Solutions - Tennessee, LLC (128385585) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aphena Pharma Solutions - Tennessee, LLC | 128385585 | REPACK(71610-182) |